Continued Use of Trastuzumab (Herceptin) after Progression on Prior Trastuzumab Therapy in HER-2-Positive Metastatic Breast Cancer

By Pusztai Lajos   Esteva Francisco  

Cancer Investigation, Vol. 24, Iss. 2, 2006-05 ,pp. : 187-191

Informa Healthcare

Access to resources Recommend Favorite

In vitro and in vivo Effects of Combination of Trastuzumab (Herceptin) and Tamoxifen in Breast Cancer

By Wang Chun-Xia   Koay Debbie   Edwards Andrea   Lu Zhao   Mor Gil   Ocal Idris   DiGiovanna Michael  

Breast Cancer Research and Treatment, Vol. 92, Iss. 3, 2005-08 ,pp. : 251-263

Springer Publishing Company

Access to resources Recommend Favorite

Selection of HER-2/neu-positive tumor cells in early stage cervical cancer: implications for Herceptin-mediated therapy

By Bellone S.   Palmieri M.   Gokden M.   Joshua J.   Roman J.J.   Pecorelli S.   Cannon M.J.   Santin A.D.  

Gynecologic Oncology, Vol. 91, Iss. 1, 2003-10 ,pp. : 231-240

Elsevier

Access to resources Recommend Favorite

CD1d-restricted mouse Vα14 and human Vα24 T cells: lymphocytes of innate immunity

By Benlagha K.   Bendelac A.  

Seminars in Immunology, Vol. 12, Iss. 6, 2000-12 ,pp. : 537-542

Academic Press

Access to resources Recommend Favorite

The 2-adrenergic receptor and Her2 comprise a positive feedback loop in human breast cancer cells

By Shi Ming  

Breast Cancer Research and Treatment, Vol. 125, Iss. 2, 2011-01 ,pp. : 351-362

Springer Publishing Company

Access to resources Recommend Favorite